CCR2 and breast cancer: Instead of using Ccr2-/- mice, Brummer et al. knocked down CCR2 expression in mammary tumors that developed after intraductal injection of MMTV-PyMT mammary carcinoma cells with siRNAs complexed to TAT cell penetrating peptides by calcium cross-linking.